Generative AI develops potential new drugs for antibiotic-resistant bacteria
Generative artificial intelligence model, SyntheMol, designed novel drugs to combat antibiotic resistance.
SyntheMol's innovative approach uses AI to create entirely new molecules for potential drug development.